Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
CC BY
Saved in:
Main Authors: | Marius, Trøseid, José R., Arribas, Lambert, Assoumou |
---|---|
Format: | Book |
Language: | English |
Published: |
Springer
2023
|
Subjects: | |
Online Access: | https://link.springer.com/article/10.1186/s13054-022-04205-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7298 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock a double-blind, randomized, placebo-controlled trial
by: Thomas, Daix, et al.
Published: (2023) -
The 1991 Child Support Act
by: McCarthy-Cotter, Leanne
Published: (2022) -
AI as a challenge for legal regulation – the scope of application of the artificial intelligence act proposal
by: Ruschemeier, Hannah
Published: (2023) -
Review of Stephen P. Garvey, Guilty Acts, Guilty Minds (Oxford: Oxford University Press, 2020)
by: Bennett, Christopher
Published: (2023) -
The Pericapsular Nerve Group (PENG) block combined with Local Infiltration Analgesia (LIA) compared to placebo and LIA in hip arthroplasty surgery a multi-center double-blinded randomized-controlled trial
by: D.-Yin, Lin, et al.
Published: (2023)